These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8813610)

  • 1. Evidence that the NH2-terminus of substance P modulates N-methyl-D-aspartate-induced activity by an action involving sigma receptors.
    Hornfeldt CS; Kitto KF; Larson AA
    Eur J Pharmacol; 1996 Jun; 306(1-3):15-22. PubMed ID: 8813610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity.
    Larson AA; Sun X
    Neuropharmacology; 1993 Sep; 32(9):909-17. PubMed ID: 7694172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptics with differential affinities at dopamine D2 receptors and sigma receptors affect differently the N-methyl-D-aspartate-induced increase in intracellular calcium concentration: involvement of protein kinase.
    Hayashi T; Su TP; Kagaya A; Nishida A; Shimizu M; Yamawaki S
    Synapse; 1999 Jan; 31(1):20-8. PubMed ID: 10025680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
    Monnet FP; Debonnel G; Bergeron R; Gronier B; de Montigny C
    Br J Pharmacol; 1994 Jun; 112(2):709-15. PubMed ID: 8075892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
    Bergeron R; de Montigny C; Debonnel G
    Br J Pharmacol; 1997 Apr; 120(7):1351-9. PubMed ID: 9105712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine is mediated by sigma activity.
    Kreeger JS; Yukhananov RYu ; Larson AA
    Brain Res; 1995 Feb; 672(1-2):83-8. PubMed ID: 7749756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors.
    Bergeron R; de Montigny C; Debonnel G
    J Neurosci; 1996 Feb; 16(3):1193-202. PubMed ID: 8558248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency.
    Monnet FP; Blier P; Debonnel G; de Montigny C
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):32-9. PubMed ID: 1407002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.
    Brent PJ
    Psychopharmacology (Berl); 1991; 105(3):421-7. PubMed ID: 1686818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus.
    Bermack JE; Debonnel G
    Synapse; 2005 Jan; 55(1):37-44. PubMed ID: 15499608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
    Monnet FP; Debonnel G; Fournier A; de Montigny C
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1219-25. PubMed ID: 1469630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
    DeLander GE; Wahl JJ
    Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytochromes P-450 are not involved in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus.
    Monnet FP; Debonnel G; de Montigny C
    Synapse; 1993 Jan; 13(1):30-8. PubMed ID: 8427011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NH2-terminus of substance P modulates NMDA-induced activity in the mouse spinal cord.
    Hornfeldt CS; Sun X; Larson AA
    J Neurosci; 1994 May; 14(5 Pt 2):3364-9. PubMed ID: 7514216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors.
    Monnet FP; Debonnel G; Junien JL; De Montigny C
    Eur J Pharmacol; 1990 Apr; 179(3):441-5. PubMed ID: 2163857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective reduction of N-methyl-D-aspartate-evoked responses by 1,3-di(2-tolyl)guanidine in mouse and rat cultured hippocampal pyramidal neurones.
    Fletcher EJ; Church J; Abdel-Hamid K; MacDonald JF
    Br J Pharmacol; 1993 Aug; 109(4):1196-205. PubMed ID: 8401930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
    Gronier B; Debonnel G
    Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse.
    Velázquez RA; Kitto KF; Larson AA
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1231-7. PubMed ID: 9190858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with NMDA antagonist, CGP 37849, and sigma receptor agonists, SA4503 or DTG, decreases the neuroleptic-induced catalepsy in rats.
    Skuza G
    Pol J Pharmacol; 2000; 52(4):313-6. PubMed ID: 11345488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.